Cobra Sexual Energy Deceptive Advertising California Settlement

Settlement Structure: Claims Made

Active: Closed

Closed Settlement Statement:

According to court documents, the claim submission deadline has passed. Please contact the claims administrator if you have any questions.

Case Summary:

This settlement resolves a lawsuit against Nutraceutical Corporation about sales of its Cobra Sexual Energy. The complaint alleged that certain elements on the product’s label falsely advertised it as an aphrodisiac, and also that the product was an “unapproved new drug” that was not approved by the Food and Drug Administration.

Docket Number:


Company: Nutraceutical

Filing Deadline: March 6, 2021

Class Period: August 14, 2009 to December 31, 2020

Objection Deadline: March 6, 2021

Exclusion Deadline: March 6, 2021

Final Approval Hearing: April 2, 2021

Proof of Purchase:

You do not need to provide proof, but you will get a larger payment if you do.


You may be eligible if you are a resident of California who bought Cobra, for personal or household use and not for resale, between August 14, 2009 and December 31, 2020.

Typical Settlement Amount:

Without proof: Estimated at $10. With proof: Up to $100. Final amounts will depend on the number of valid claims received. Also, Cobra has agreed to remove the words “potency wood” and “virility” from future Cobra labels.

Total Settlement Amount: $100,000

Class Representative Proposed Incentive Fee:


Law Firms:
Law Offices of Ronald A. Marron
Weston Firm

Claim Form: Cobra Sexual Energy Deceptive Advertising California Settlement Claim Form

Case Name: In re Cobra Sexual Energy Sales Practices Litigation

Settlement Website: Cobra Sexual Energy Deceptive Advertising California Settlement Website

Claims Administrator:
Classaura Class Action Administration

Claims Administrator Contact Information:

Cobra Sexual Energy Litigation
c/o Classaura Class Action Administration
1718 Peachtree St NW #1080
Atlanta, GA 30309

Tags: Aphrodisiac Claims, Deceptive Advertising, Deceptive Labels, Druglike Claims